Clinical Trial

Treatment of Focal Ventricular Tachycardias Using a Pulsed Field Ablation From a Point Ablation Catheter Short Title FOCUS-PFA

Study acronym: FOCUS PFA
Enrolling by Invitation
View on ClinicalTrials.gov →
Summary
The purpose of this study is to examine the use of a point ablation catheter (Farapoint, Boston Scientific) in the mapping and ablation of focal ventricular arrhythmias (premature ventricular contractions or ventricular tachycardia) using pulsed field energy.
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2024-12-18; most recent amendment 2026-02-09.
Status change: Recruiting → Enrolling by Invitation 2026-02-09
Status change: Not Yet Recruiting → Recruiting 2025-02-05
Trial Details
NCT Number NCT06747013
Lead Sponsor Vivek Reddy
Collaborators: Boston Scientific Corporation
Conditions Focal Ventricular Arrhythmias, Premature Ventricular Contractions, Ventricular Tachycardias
Enrollment 60 participants
Start Date 2025-01-07
Primary Completion 2026-12 (estimated)
Study Completion 2026-12 (estimated)
Updated on ClinicalTrials.gov 2026-07-30